Screener
Immunovant, Inc. IMVT Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $5.06B.
The source filing: Immunovant, Inc.’s 10-K, filed May 20, 2026. Open the filing →
- Filed
- May 20, 2026, 7:28 AM EDT
- Fiscal year
- FY2026
- Accession
- 0001764013-26-000064
FAQ
- What is Immunovant, Inc.'s market capitalization?
- Immunovant, Inc. (IMVT) reported market capitalization of $5.06B in Q1 2026.
- How has Immunovant, Inc.'s market capitalization changed year-over-year?
- Immunovant, Inc.'s market capitalization increased by 74.2% year-over-year, from $2.9B to $5.06B.
- What is the long-term trend for Immunovant, Inc.'s market capitalization?
- Over 5 years (2021 to 2026), Immunovant, Inc.'s market capitalization has grown at a 26.3% compound annual growth rate (CAGR), from $1.57B to $5.06B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Immunovant, Inc.'s market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude